Purchase Order 75N92024P00031
Award Date 1/19/24
Potential Completion Date 1/19/25
Potential Value $35K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $24,264 purchase order to Oxford Nanopore Technologies Inc. for the delivery of unspecified products or services. Performance will take place in New York, NY under a firm fixed price arrangement concluding on September 29, 2023. As the NIH/NHGRI supports genomic research to analyze DNA and interpret the book of life, this contract is likely to provide Oxford Nanopore's...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health, National Human Genome Research Institute to Oxford Nanopore Technologies Inc. for a PROMETHION 24 system. The contract has a completion date of July 31, 2019 and a potential value of $165,000.00. The contract does not have a set-aside designation. Based on Oxford Nanopore Technologies Inc.'s past federal contract work, they provide next-generation genomic...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $12,500.00 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a 12-month software license and device warranty on a GridION system. The award period runs from August 9, 2021, to August 8, 2022, and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of nanopore-based...
- This is a $21,835.00 firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The purpose of the award is to provide a reagent needed by Shelise Brooks for the preparation of direct RNA libraries for sequencing on the Oxford Nanopore Promethion system in support of the Collins NF_Isletbetacells project led by Dr. Mike Erdos at NHGRI. The contract...
- The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a $11,508.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of 3 packs of 4 PROMETHION flow cell packs (RNA), with an ultimate completion date of August 7, 2024. This equipment supports NHGRI's ongoing genomics research initiatives, which utilize Oxford...
- This is a $150,000.00 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a license and warranty for a PromethION 48 DNA/RNA sequencing system, with a period of performance through October 27, 2029. Oxford Nanopore Technologies has secured multiple prime contracts and...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc. for $0.00. The contract has no set-aside designation and calls for delivery of products or services by June 11, 2020 in support of the agency's genome research efforts. As the leading federal funder and coordinator of genome research, this contract likely provides the Institute with nanopore sequencing...
- The National Human Genome Research Institute (NHGRI), a civilian agency, awarded a $23,590.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the supply of 3 packs of 4 PromethION flow cell packs (RNA) with a period of performance through December 31, 2024. This award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contract awards from agencies such as the National...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $12,500 purchase order to Oxford Nanopore Technologies Inc. for an annual software and device warranty for GridION DNA sequencing instruments. The contract period is from September 1, 2023 through August 31, 2024. Oxford Nanopore Technologies Inc. will provide the warranty services for the GridION instruments under a firm fixed price contract. The place...
- This federal contract award was made by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $376,365.00 firm fixed-price purchase order is for the delivery of PromethION Instrument Reagents, which support the agency's genomic research and analysis work. The contract has an ultimate completion date of June 30, 2026 and does not utilize any...